181 related articles for article (PubMed ID: 33710605)
21. WDR5 promotes the tumorigenesis of oral squamous cell carcinoma via CARM1/β-catenin axis.
Lyu XY; Shui YS; Wang L; Jiang QS; Meng LX; Zhan HY; Yang R
Odontology; 2022 Jan; 110(1):138-147. PubMed ID: 34398317
[TBL] [Abstract][Full Text] [Related]
22. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR‑149‑5p/CDK6 axis.
Lv T; Liu H; Wu Y; Huang W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880596
[TBL] [Abstract][Full Text] [Related]
24. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
25. Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways.
Li Y; Jia S; Dai W
Drug Des Devel Ther; 2020; 14():773-782. PubMed ID: 32158195
[TBL] [Abstract][Full Text] [Related]
26. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
27. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
28. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma.
Zhang J; Mao W; Dai Y; Qian C; Dong Y; Chen Z; Meng L; Jiang Z; Huang T; Hu J; Luo P; Korner H; Jiang Y; Ying S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):562-570. PubMed ID: 31139826
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
30. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
31. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis.
Wang D; Qi H; Zhang H; Zhou W; Li Y; Li A; Liu Q; Wang Y
Int J Biol Sci; 2020; 16(7):1180-1193. PubMed ID: 32174793
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
Feng H; Zhang X; Lai W; Wang J
Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
Sun M; Shen Z
Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
[TBL] [Abstract][Full Text] [Related]
34. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
35. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
Dai D; Feng XD; Zhu WQ; Bao YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
[TBL] [Abstract][Full Text] [Related]
36. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.
Levy D; Kuo AJ; Chang Y; Schaefer U; Kitson C; Cheung P; Espejo A; Zee BM; Liu CL; Tangsombatvisit S; Tennen RI; Kuo AY; Tanjing S; Cheung R; Chua KF; Utz PJ; Shi X; Prinjha RK; Lee K; Garcia BA; Bedford MT; Tarakhovsky A; Cheng X; Gozani O
Nat Immunol; 2011 Jan; 12(1):29-36. PubMed ID: 21131967
[TBL] [Abstract][Full Text] [Related]
37. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity.
Fukuda M; Ehara M; Suzuki S; Ohmori Y; Sakashita H
Int J Oncol; 2010 Jun; 36(6):1355-65. PubMed ID: 20428758
[TBL] [Abstract][Full Text] [Related]
38. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
40. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
